Determinations of ephedrine in mixtures of ephedrine and pseudoephedrine using diffuse reflectance infrared spectroscopy

International Journal of Pharmaceutics

Volumn 289, Issue 1-2, 2005, Pages 39-49

  Dijiba, Yanga K ^a   Zhang, Anding ^a   Niemczyk, Thomas M ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Ephedrine; Infrared spectroscopy; Partial least squares analysis

Indexed keywords

EPHEDRINE; PSEUDOEPHEDRINE;

ARTICLE; CALIBRATION; DATA ANALYSIS; DIFFUSE REFLECTANCE SPECTROSCOPY; ERROR; INFRARED SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; SOLID; SOLID STATE; STANDARDIZATION;

AMINO ALCOHOLS; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; EPHEDRINE; SPECTROPHOTOMETRY, INFRARED; STEREOISOMERISM; TECHNOLOGY, PHARMACEUTICAL;

EID: 11844251999     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.09.027     Document Type: Article

References (30)

1. H.Y. Aboul-Enein Applications of solid-state nuclear magnetic resonance spectroscopy to pharmaceutical research Spectroscopy 5 1990 32 40
2. H.Y. Aboul-Enein, A.A. Bunaciu, and S. Fleschin Analysis of mebendazole polymorphs by Fourier transform IR spectrometry using chemometric methods Biopolymers (Biospectroscopy) 67 2002 56 60
3. R. Bergin Refinement of the structure of (-)-ephedrine hydrochloride Acta Cryst. B27 1971 381 386
4. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch, and C. de la Pezuela Effect of data preprocessing methods in near-infrared diffuse reflectance spectroscopy for the determination of the active compound in a pharmaceutical preparation Appl. Spectrosc. 51 1997 240 246
5. M. Blanco, and A. Villar Polymorphic analysis of a pharmaceutical preparation by NIR spectroscopy Analyst 125 2000 2311 2314
6. P.J. Brimmer, and P.R. Griffiths Angular dependence of diffuse reflectance infrared spectra. Part III: linearity of Kubelka-Munk plots Appl. Spectrosc. 42 1988 242 247
7. H.G. Brittain, S.J. Bogdanowich, D.E. Bugay, J. DeVincentis, G. Lewen, and A.W. Newman Physical characterizations of pharmaceutical solids Pharm. Res. 8 1991 963 973
8. S.R. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, and C. Poochikian Pharmaceutical solids: a strategic approach to regulatory considerations Pharm. Res. 12 1995 945 954
9. M.R. Caira Crystalline polymorphism of organic compounds Top. Cur. Chem. 198 1998 163 208
10. E.W. Ciurczak Uses of near-infrared spectroscopy in pharmaceutical analysis Appl. Spectrosc. Rev. 23 1987 147 163
11. C.M. Deeley, R.A. Spragg, and T.L. Threlfall A comparison of Fourier transform infrared and near-infrared Fourier transform Raman spectroscopy for quantitative measurements: an application in polymorphism Spectrochim. Acta 47A 1991 1217 1223
12. D.H. Doff, F.L. Brownen, and O.I. Corrigan Determination of α-impurities in the β-polymorph of inosine using infrared spectroscopy and X-ray powder diffraction Analyst 111 1986 179 182
13. 13C CP/MAS NMR Pharm. Res. 13 1996 1095 1104
14. P. Geladi, D. MacDougall, and H. Martens Linearization and scatter-correction for near-infrared reflectance spectra of meat Appl. Spectrosc. 39 1985 491 500
15. R. Gimet, and A.T. Luong Quantitative determination of polymorphic forms in a formulation matrix using the near infra-red reflectance analysis technique J. Pharm. Biomed. Anal. 5 1987 205 211
16. K.J. Hartauer, E.S. Miller, and J. Keith Guillory Diffuse reflectance infrared Fourier transform spectroscopy for the quantitative analysis of mixtures of polymorphs Int. J. Pharm. 85 1992 163 174
17. T. Isaksson, and T. NÆs The effect of multiplicative scatter correction (MSC) and linearity improvement in NIR spectroscopy Appl. Spectrosc. 42 1988 1273 1284
18. G. Jalsovszky, O. Egyed, S. Holly, and B. Hegedus Investigation of the morphological composition of cimetidine by FT-Raman spectroscopy Appl. Spectrosc. 49 1995 1142 1145
19. K.R. Lee, G. Zuber, and L. Katrincic Chemometrics approach to the determination of polymorphism of a drug compound by infrared spectroscopy Drug Dev. Ind. Pharm. 26 2000 135 147
20. S.K. Loyalka, and C.A. Riggs Inverse problem in diffuse reflectance spectroscopy: accuracy of the Kubelka-Munk equations Appl. Spectrosc. 49 1995 1107 1110
21. M. Mathew, and G.J. Palenik The crystal and molecular structures of (+)-pseudoephedrine and (+)-pseudoephedrine hydrochloride Acta Cryst. B33 1977 1016 1022
22. A.D. Patel, P.E. Luner, and M.S. Kemper Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopy Int. J. Pharm. 206 2000 63 74
23. J.B. Reeves, and V.B. Reeves Effects of apodization function, zero filling, background spectra, and absorbance transformation on mid-infrared calibrations for feed composition Spectrosc. Lett. 35 2002 663 680
24. P.J. Saindon, N.S. Cauchon, P.A. Sutton, C.-J. Chang, G.E. Peck, and S.R. Byrn Solid-state nuclear magnetic resonance (NMR) spectra of pharmaceutical dosage forms Pharm. Res. 10 1993 197 203
25. A. Salari, and R.E. Young Application of attenuated total reflectance FTIR spectroscopy to the analysis of mixtures of pharmaceutical polymorphs Int. J. Pharm. 163 1998 157 166
26. W.F. Schmidt, W. Porter, and J.T. Carstensen Thermodynamics in the prediction of the solubilities of binary mixtures of the diastereoisomers and enantiomers of ephedrine Pharm. Res. 5 1988 391
27. 2O) in a mixture by solid-state nuclear magnetic resonance (NMR) Pharm. Res. 7 1990 184 187
28. T.L. Threlfall Analysis of organic polymorphs: a review Analyst 120 1995 2435 2460
29. A.M. Tudor, S.J. Church, P.J. Hendra, M.C. Davies, and C.D. Melia The qualitative and quantitative analysis of chlorpropamide polymorphic mixtures by near-infrared Fourier transform Raman spectroscopy Pharm. Res. 10 1993 1772 1776
30. W.E. Vargas, and G.A. Niklasson Applicability conditions of the Kubelka-Munk theory Appl. Opt. 36 1997 5580 5586